Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rogaratinib × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4 Tumor-Agnostic 3 Thoracic 2 Head & Neck 2 Breast 2 Other neoplasm 1

Conditions

Breast Cancer Metastatic 1

Interventions

Biopsy 8 Polymerase Chain Reaction 6 Peripheral Blood Stem Cell Transplantation 5 Epoetin Alfa 5 Surveys and Questionnaires 4 Sulindac 4 Microarray Analysis 4 Gene Expression Profiling 4 Early Intervention, Educational 4 Cyclophosphamide 4 Colposcopy 4 Cisplatin 4 Cetuximab 4 Celecoxib 4 fludarabine phosphate 3 Vaginal Smears 3 Selenium 3 Pemetrexed 3 Methotrexate 3 Imiquimod 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Eflornithine 3 Darbepoetin alfa 3 Aspirin 3 Antilymphocyte Serum 3 Whole-Body Irradiation 2 Vitamin E 2 Videotape Recording 2 Tacrolimus 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡